Cargando…
Current and Emerging Therapies for COVID-19 in Lung Transplantation
PURPOSE OF REVIEW: The landscape of the coronavirus disease 2019 (COVID-19) pandemic has rapidly changed over the past 3 years. Paralleling this evolution, the scientific and medical communities have reported many novel findings relating to the infection’s epidemiology, transmission, diagnosis, and...
Autores principales: | Friedman, Daniel Z. P., Pettit, Natasha N., MacKenzie, Erica, Pisano, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932416/ https://www.ncbi.nlm.nih.gov/pubmed/36820015 http://dx.doi.org/10.1007/s13665-023-00302-3 |
Ejemplares similares
-
2669. Evaluation of Post-Operative Acute Kidney Injury with Piperacillin–Tazobactam Combined with Vancomycin for Lung Transplant Prophylaxis
por: Pettit, Natasha N, et al.
Publicado: (2019) -
1103. Improving Perioperative Prophylactic Antimicrobial Guideline Concordance in Liver and Lung Transplant Recipients
por: Nguyen, Cynthia T, et al.
Publicado: (2019) -
Bacterial infections in lung transplantation
por: McCort, Margaret, et al.
Publicado: (2021) -
Current and emerging treatment options for spinal muscular atrophy
por: Farooq, Faraz, et al.
Publicado: (2015) -
474 Ceftaroline Salvage Therapy for MRSA Bacteremia Following Vancomycin Failure
por: Pettit, Natasha, et al.
Publicado: (2014)